157 related articles for article (PubMed ID: 25624908)
1. Tamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling pathway.
Xie X; Wu MY; Shou LM; Chen LP; Gong FR; Chen K; Li DM; Duan WM; Xie YF; Mao YX; Li W; Tao M
Oncol Lett; 2015 Feb; 9(2):837-844. PubMed ID: 25624908
[TBL] [Abstract][Full Text] [Related]
2. Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway.
Li W; Chen Z; Gong FR; Zong Y; Chen K; Li DM; Yin H; Duan WM; Miao Y; Tao M; Han X; Xu ZK
Eur J Cancer; 2011 Nov; 47(17):2654-64. PubMed ID: 21958460
[TBL] [Abstract][Full Text] [Related]
3. Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin.
Shou LM; Zhang QY; Li W; Xie X; Chen K; Lian L; Li ZY; Gong FR; Dai KS; Mao YX; Tao M
Oncol Rep; 2013 Sep; 30(3):1059-66. PubMed ID: 23835679
[TBL] [Abstract][Full Text] [Related]
4. Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell-cycle arrest and apoptosis.
Li W; Xie L; Chen Z; Zhu Y; Sun Y; Miao Y; Xu Z; Han X
Cancer Sci; 2010 May; 101(5):1226-33. PubMed ID: 20331621
[TBL] [Abstract][Full Text] [Related]
5. Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib.
Wang WJ; Wu MY; Shen M; Zhi Q; Liu ZY; Gong FR; Tao M; Li W
Int J Oncol; 2015 Nov; 47(5):1912-22. PubMed ID: 26398277
[TBL] [Abstract][Full Text] [Related]
6. PP2A inhibitors suppress migration and growth of PANC-1 pancreatic cancer cells through inhibition on the Wnt/β-catenin pathway by phosphorylation and degradation of β-catenin.
Wu MY; Xie X; Xu ZK; Xie L; Chen Z; Shou LM; Gong FR; Xie YF; Li W; Tao M
Oncol Rep; 2014 Aug; 32(2):513-22. PubMed ID: 24926961
[TBL] [Abstract][Full Text] [Related]
7. The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer.
Xu MD; Liu L; Wu MY; Jiang M; Shou LM; Wang WJ; Wu J; Zhang Y; Gong FR; Chen K; Tao M; Zhi Q; Li W
Oncogenesis; 2018 Nov; 7(11):94. PubMed ID: 30478299
[TBL] [Abstract][Full Text] [Related]
8. Cantharidin suppressed breast cancer MDA-MB-231 cell growth and migration by inhibiting MAPK signaling pathway.
Gu XD; Xu LL; Zhao H; Gu JZ; Xie XH
Braz J Med Biol Res; 2017 Jul; 50(7):e5920. PubMed ID: 28678918
[TBL] [Abstract][Full Text] [Related]
9. Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA.
Shen M; Wu MY; Chen LP; Zhi Q; Gong FR; Chen K; Li DM; Wu Y; Tao M; Li W
Sci Rep; 2015 Jul; 5():11836. PubMed ID: 26135631
[TBL] [Abstract][Full Text] [Related]
10. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.
Hill TA; Stewart SG; Sauer B; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
Bioorg Med Chem Lett; 2007 Jun; 17(12):3392-7. PubMed ID: 17451951
[TBL] [Abstract][Full Text] [Related]
11. The radiotherapy-sensitization effect of cantharidin: Mechanisms involving cell cycle regulation, enhanced DNA damage, and inhibited DNA damage repair.
Xu MD; Liu SL; Zheng BB; Wu J; Wu MY; Zhang Y; Gong FR; Tao M; Zhang J; Li W
Pancreatology; 2018 Oct; 18(7):822-832. PubMed ID: 30201439
[TBL] [Abstract][Full Text] [Related]
12. Cantharidin Induces Apoptosis Through the Calcium/PKC-Regulated Endoplasmic Reticulum Stress Pathway in Human Bladder Cancer Cells.
Su CC; Liu SH; Lee KI; Huang KT; Lu TH; Fang KM; Wu CC; Yen CC; Lai CH; Su YC; Huang CF
Am J Chin Med; 2015; 43(3):581-600. PubMed ID: 25967669
[TBL] [Abstract][Full Text] [Related]
13. PP2A inhibitors induce apoptosis in pancreatic cancer cell line PANC-1 through persistent phosphorylation of IKKα and sustained activation of the NF-κB pathway.
Li W; Chen Z; Zong Y; Gong F; Zhu Y; Zhu Y; Lv J; Zhang J; Xie L; Sun Y; Miao Y; Tao M; Han X; Xu Z
Cancer Lett; 2011 May; 304(2):117-27. PubMed ID: 21376459
[TBL] [Abstract][Full Text] [Related]
14. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues.
Sakoff JA; Ackland SP; Baldwin ML; Keane MA; McCluskey A
Invest New Drugs; 2002 Feb; 20(1):1-11. PubMed ID: 12003183
[TBL] [Abstract][Full Text] [Related]
15. Overview of Cantharidin and its Analogues.
Wang G; Dong J; Deng L
Curr Med Chem; 2018; 25(17):2034-2044. PubMed ID: 28413963
[TBL] [Abstract][Full Text] [Related]
16. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
Luo W; Sharif TR; Houghton PJ; Sharif M
Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
[TBL] [Abstract][Full Text] [Related]
17. Role of cantharidin in the activation of IKKα/IκBα/NF‑κB pathway by inhibiting PP2A activity in cholangiocarcinoma cell lines.
Zhou H; Xu J; Wang S; Peng J
Mol Med Rep; 2018 Jun; 17(6):7672-7682. PubMed ID: 29620225
[TBL] [Abstract][Full Text] [Related]
18. Cantharidin and norcantharidin inhibit caprine luteal cell steroidogenesis in vitro.
Twu NF; Srinivasan R; Chou CH; Wu LS; Chiu CH
Exp Toxicol Pathol; 2012 Jan; 64(1-2):37-44. PubMed ID: 20594813
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand.
Peng F; Wei YQ; Tian L; Yang L; Zhao X; Lu Y; Mao YQ; Kan B; Lei S; Wang GS; Jiang Y; Wang QR; Luo F; Zou LQ; Liu JY
J Cancer Res Clin Oncol; 2002 Apr; 128(4):223-30. PubMed ID: 11935314
[TBL] [Abstract][Full Text] [Related]
20. Medical uses of mylabris in ancient China and recent studies.
Wang GS
J Ethnopharmacol; 1989 Sep; 26(2):147-62. PubMed ID: 2689797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
